![[libribook.com] Traumatic Scar Tissue Management 1st Edition](https://documents.yumpu.com/000/063/506/600/df9a14f39008e2ef6fb6257fe1995653691c6175/78495942476d415367326b574a577143792b587756513d3d/564747374d5059344b50354f41764d437441314573673d3d.jpg?AWSAccessKeyId=AKIAICNEWSPSEKTJ5M3Q&Expires=1726214400&Signature=nWBufQy1FauxnXyOJ7RV%2FYxhNhQ%3D)
[libribook.com] Traumatic Scar Tissue Management 1st Edition
Clinical ConsiderationIt has been identified that mechanical forces can induce changes in theexpression of ECM proteins and proteases. In a study by Kanazawa et al.(2009), it was revealed that uniaxial, cyclical stretching of skin fibroblastsresulted in down-regulation of agents known to stimulate persistentcollagen proliferation associated with fibrosis and abnormal scarring. Inanother in vitro model, human hypertrophic scar samples responded tomechanical loading by inducing apoptosis (Derderian et al. 2005).Although the exact mechanism remains to be determined, it ishypothesized that massage can impact cellular structural and signalingmilieu, thereby inducing beneficial effects through the ability to affectfibroblast apoptosis and remodeling (Bhadal et al. 2008, Chan et al. 2010,Cho et al. 2014).
Clinical ConsiderationHypertrophy typically persists for 6–12 months and tends to regress over aperiod of 18–24 months (Oliveria et al. 2005). Pruritus is more likely tooccur during active hypertrophy (i.e. early stages of maturation). It isprudent that the evolution of hypertrophic scars – whether the burn scar isin the early or late states of maturation – inform treatment protocol.Additionally, staging will impact short and long-term outcomes (Cho et al.2014).
- Page 464 and 465: ImmobilizationThe impact of immobil
- Page 467 and 468: Figure 5.4The fall-out associated w
- Page 469 and 470: Clinical ConsiderationHere we see t
- Page 471 and 472: Pathophysiological ConsiderationAcc
- Page 473 and 474: Pathophysiological ConsiderationNeu
- Page 475 and 476: The diverse biological effects of N
- Page 477 and 478: Clinical ConsiderationCareful appli
- Page 479 and 480: Clinical ConsiderationSome patholog
- Page 481 and 482: Pathophysiological ConsiderationSom
- Page 483 and 484: compressive effect in the keloidal
- Page 485 and 486: alterations in the mechanical envir
- Page 487 and 488: Clinical ConsiderationMechanical fo
- Page 489 and 490: Table 5.4Role of neuropeptides (NP)
- Page 491 and 492: Fitch P (2005) Scars of life. Journ
- Page 493 and 494: Langevin HM (2006) Connective tissu
- Page 495 and 496: active scars. Journal of Bodywork a
- Page 497 and 498: trauma.
- Page 499 and 500: Clinical ConsiderationPostsurgical
- Page 501 and 502: following burn injury,bacterial col
- Page 503 and 504: Table 6.1Comparison of scars (Ogawa
- Page 505 and 506: Pathophysiological ConsiderationAcc
- Page 507 and 508: BurnsA burn injury to the skin or o
- Page 510 and 511: Figure 6.1Depth of burn trauma and
- Page 512 and 513: • Stimulate ECM formation• Regu
- Page 516 and 517: Clinical ConsiderationMT may be a v
- Page 518 and 519: ThermoregulationThermoregulation (t
- Page 520 and 521: from the tissues and taken up by th
- Page 522 and 523: treatment strategies are difficult
- Page 524 and 525: Clinical ConsiderationSkin rolling
- Page 526 and 527: Sequelae and ComplicationsAdvances
- Page 528 and 529: • Paresthesia - 47%• Arm/should
- Page 530 and 531: breast or around the edge of the ar
- Page 532 and 533: Radiation scarringScar tissue as a
- Page 534 and 535: Implants and painPain of fluctuatin
- Page 536 and 537: LymphedemaBreast cancer treatment o
- Page 538 and 539: volume of fluid that accumulates or
- Page 540 and 541: OneTwoThreeCommonly referred to as
- Page 542 and 543: myokinetic chain/myofascial meridia
- Page 544: • Loss of touch sensation• Clum
- Page 548 and 549: Figure 6.3Distribution of nerves in
- Page 550 and 551: include preservation of as much of
- Page 552 and 553: complication is present there is de
- Page 554 and 555: Clinical ConsiderationScar complica
- Page 556 and 557: BreastCancer.org (2015c) Side Effec
- Page 558 and 559: 323-9.Kania A (2012) Scars. In: Dry
- Page 560 and 561: Slemp AE, Kirschner RE (2006) Keloi
- Page 562 and 563: scar tissue, while being mindful of
Clinical Consideration
Hypertrophy typically persists for 6–12 months and tends to regress over a
period of 18–24 months (Oliveria et al. 2005). Pruritus is more likely to
occur during active hypertrophy (i.e. early stages of maturation). It is
prudent that the evolution of hypertrophic scars – whether the burn scar is
in the early or late states of maturation – inform treatment protocol.
Additionally, staging will impact short and long-term outcomes (Cho et al.
2014).
Change language